Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

I would think if Leo had bottom-line data it would have be been PR'd yesterday. According to Leo Based upon top-line data CTIX has decided that a pivotal Phase 3 trial in 2015 will be for a single-dose of Brilacidin for ABSSSI. Holding back even mediocre data would reflect poorly to Leo's credibility. I just don't see the latter. There's a lot riding on B at this juncture.